High level expression of LYN, a member of the SRC family of non-receptor tyrosine kinases, has been associated with epithelial/mesenchymal transition and invasion by breast cancer cells and with poor survival of breast cancer patients [15]. This evidence concerns the gene LYN and breast carcinoma.